Placebo Effects in Psychotherapy: A Framework
Author(s) -
Paul Enck,
Stephan Zipfel
Publication year - 2019
Publication title -
frontiers in psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.363
H-Index - 67
ISSN - 1664-0640
DOI - 10.3389/fpsyt.2019.00456
Subject(s) - psychotherapist , placebo , context (archaeology) , blinding , psychology , psychological intervention , modalities , clinical psychology , medicine , clinical trial , psychiatry , alternative medicine , paleontology , social science , pathology , sociology , biology
The issue of placebo response and the extent of its effect on psychotherapy is complex for two specific reasons: i) Current standards for drug trials, e.g., true placebo interventions, double-blinding, cannot be applied to most psychotherapy techniques, and ii) some of the “nonspecific effects” in drug therapy have very specific effects in psychotherapy, such as the frequency and intensity of patient–therapist interaction. In addition, different psychotherapy approaches share many such specific effects (the “dodo bird verdict”) and lack specificity with respect to therapy outcome. Here, we discuss the placebo effect in psychotherapy under four aspects: a) nonspecific factors shared with drug therapy (context factors); b) nonspecific factors shared among all psychotherapy traditions (common factors); c) specific placebo-controlled options with different psychotherapy modalities; and d) nonspecific control options for the specific placebo effect in psychotherapy. The resulting framework proposes that the exploration and enumeration of context factors, common factors, and specific factors contributes to the placebo effects in psychotherapy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom